Nathan A. Pennell
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study(2020)1,787 cited
- → Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study(2008)1,237 cited
- → Reactive microgliosis(1999)1,082 cited
- → Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRAS G12C Mutation(2022)908 cited
- → Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer(2020)816 cited
- → Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology(2017)599 cited
- → Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer(2017)490 cited
- → Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer(2010)476 cited
- → NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020(2020)472 cited
- → Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium(2021)325 cited